339 related articles for article (PubMed ID: 33409153)
1. Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview.
Barbato A; Scandura G; Puglisi F; Cambria D; La Spina E; Palumbo GA; Lazzarino G; Tibullo D; Di Raimondo F; Giallongo C; Romano A
Front Oncol; 2020; 10():604143. PubMed ID: 33409153
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy.
Mohammadalipour A; Dumbali SP; Wenzel PL
Front Cell Dev Biol; 2020; 8():603292. PubMed ID: 33365311
[TBL] [Abstract][Full Text] [Related]
4. Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.
Roy Chowdhury S; Banerji V
Oxid Med Cell Longev; 2018; 2018():2426712. PubMed ID: 29682155
[TBL] [Abstract][Full Text] [Related]
5. A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors.
Alam MM; Lal S; FitzGerald KE; Zhang L
Clin Transl Med; 2016 Mar; 5(1):3. PubMed ID: 26812134
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia.
Liu J; Masurekar A; Johnson S; Chakraborty S; Griffiths J; Smith D; Alexander S; Dempsey C; Parker C; Harrison S; Li Y; Miller C; Di Y; Ghosh Z; Krishnan S; Saha V
Oncotarget; 2015 Dec; 6(40):43048-64. PubMed ID: 26474278
[TBL] [Abstract][Full Text] [Related]
7. [Research Progress of Intercellular Mitochondrial Transfer in the Development of Hematological Malignant Tumors --Review].
Zhang LY; Xiang YH; Zhang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):310-313. PubMed ID: 35123645
[TBL] [Abstract][Full Text] [Related]
8. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
[TBL] [Abstract][Full Text] [Related]
9. Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells.
Matula Z; Mikala G; Lukácsi S; Matkó J; Kovács T; Monostori É; Uher F; Vályi-Nagy I
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298674
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial transfer in hematological malignancies.
Guo X; Can C; Liu W; Wei Y; Yang X; Liu J; Jia H; Jia W; Wu H; Ma D
Biomark Res; 2023 Oct; 11(1):89. PubMed ID: 37798791
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.
Jitschin R; Hofmann AD; Bruns H; Giessl A; Bricks J; Berger J; Saul D; Eckart MJ; Mackensen A; Mougiakakos D
Blood; 2014 Apr; 123(17):2663-72. PubMed ID: 24553174
[TBL] [Abstract][Full Text] [Related]
12. Intermittent hypoxia leads to functional reorganization of mitochondria and affects cellular bioenergetics in marine molluscs.
Ivanina AV; Nesmelova I; Leamy L; Sokolov EP; Sokolova IM
J Exp Biol; 2016 Jun; 219(Pt 11):1659-74. PubMed ID: 27252455
[TBL] [Abstract][Full Text] [Related]
13. CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma.
Marlein CR; Piddock RE; Mistry JJ; Zaitseva L; Hellmich C; Horton RH; Zhou Z; Auger MJ; Bowles KM; Rushworth SA
Cancer Res; 2019 May; 79(9):2285-2297. PubMed ID: 30622116
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondria in cancer: current concepts and immunotherapy approaches.
Pustylnikov S; Costabile F; Beghi S; Facciabene A
Transl Res; 2018 Dec; 202():35-51. PubMed ID: 30144423
[TBL] [Abstract][Full Text] [Related]
15. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.
Pavlides S; Tsirigos A; Vera I; Flomenberg N; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 Jun; 9(11):2201-19. PubMed ID: 20519932
[TBL] [Abstract][Full Text] [Related]
16. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
17. Functional Mitochondria in Health and Disease.
Herst PM; Rowe MR; Carson GM; Berridge MV
Front Endocrinol (Lausanne); 2017; 8():296. PubMed ID: 29163365
[TBL] [Abstract][Full Text] [Related]
18. ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts.
Grings M; Seminotti B; Karunanidhi A; Ghaloul-Gonzalez L; Mohsen AW; Wipf P; Palmfeldt J; Vockley J; Leipnitz G
Sci Rep; 2019 Sep; 9(1):12651. PubMed ID: 31477743
[TBL] [Abstract][Full Text] [Related]
19. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.
Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F
Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560
[TBL] [Abstract][Full Text] [Related]
20. Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria.
Ryoo IG; Kwak MK
Toxicol Appl Pharmacol; 2018 Nov; 359():24-33. PubMed ID: 30236989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
